scholarly article | Q13442814 |
P356 | DOI | 10.1165/RCMB.2004-0187OC |
P698 | PubMed publication ID | 15640437 |
P50 | author | Barbara Rothen-Rutishauser | Q38549280 |
Stephen G Kiama | Q41916119 | ||
P2093 | author name string | Peter Gehr | |
P2860 | cites work | Occludin: a novel integral membrane protein localizing at tight junctions | Q24657666 |
Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products | Q24678867 | ||
Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin | Q24682664 | ||
ZO-3, a novel member of the MAGUK protein family found at the tight junction, interacts with ZO-1 and occludin | Q24683294 | ||
Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria | Q29619620 | ||
Cadherin cell adhesion receptors as a morphogenetic regulator | Q29620503 | ||
Dynamics of tight and adherens junctions under EGTA treatment | Q31103040 | ||
Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages? | Q31963533 | ||
MDCK cell cultures as an epithelial in vitro model: cytoskeleton and tight junctions as indicators for the definition of age-related stages by confocal microscopy. | Q32046981 | ||
Airway surfactant, a primary defense barrier: mechanical and immunological aspects | Q33573190 | ||
A life stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis, and translocation from the liver to the draining lymph | Q36366346 | ||
Dendritic cells in the respiratory tract. | Q37869630 | ||
The efficiency of the translocation of Mycobacterium tuberculosis across a bilayer of epithelial and endothelial cells as a model of the alveolar wall is a consequence of transport within mononuclear phagocytes and invasion of alveolar epithelial ce | Q39653495 | ||
A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells | Q39974160 | ||
Tight junctions. Their structure, composition, and function | Q40191878 | ||
Endocytosis of ultrafine particles by A549 cells | Q40830984 | ||
Phospholipid biosynthesis and secretion by a cell line (A549) which resembles type II alveolar epithelial cells | Q40907866 | ||
Cell lines of pulmonary and non-pulmonary origin as tools to study the effects of house dust mite proteinases on the regulation of epithelial permeability | Q40993407 | ||
Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism | Q41007702 | ||
Lung epithelial cell (A549) interaction with unopsonized environmental particulates: quantitation of particle-specific binding and IL-8 production | Q41170436 | ||
Inhibition of phagocytosis and plasma membrane mobility of the cultivated macrophage by cytochalasin B. Role of subplasmalemmal microfilaments | Q41182472 | ||
Crystals of the Chlamydomonas reinhardtii cell wall: polymerization, depolymerization, and purification of glycoprotein monomers | Q41485038 | ||
Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes | Q42241451 | ||
In vitro-generated respiratory mucosa: a new tool to study inhalational anthrax | Q44451022 | ||
Lung macrophages: how many kinds are there? What do they do? | Q48104295 | ||
Airway macrophages. The importance of the fixation method | Q48672999 | ||
Matrix metalloproteinase-9-deficient dendritic cells have impaired migration through tracheal epithelial tight junctions. | Q51640421 | ||
Influence of surface chemistry and topography of particles on their immersion into the lung's surface-lining layer. | Q51689157 | ||
Evaluation of Phagocytic Activity in Human Monocyte-Derived Dendritic Cells | Q58589453 | ||
P433 | issue | 4 | |
P304 | page(s) | 281-289 | |
P577 | publication date | 2005-01-07 | |
P1433 | published in | American Journal of Respiratory Cell and Molecular Biology | Q4744268 |
P1476 | title | A three-dimensional cellular model of the human respiratory tract to study the interaction with particles | |
P478 | volume | 32 |
Q35996109 | 3D Reconstruction of the Human Airway Mucosa In Vitro as an Experimental Model to Study NTHi Infections |
Q36148427 | A Triple Co-Culture Model of the Human Respiratory Tract to Study Immune-Modulatory Effects of Liposomes and Virosomes |
Q92859304 | A co-culture model of the bovine alveolus |
Q39043463 | A microdevice for parallelized pulmonary permeability studies. |
Q39128827 | A multiphase fluidic platform for studying ventilator-induced injury of the pulmonary epithelial barrier |
Q33588457 | A new look at the pathogenesis of asthma |
Q55497562 | A novel sample holder for 4D live cell imaging to study cellular dynamics in complex 3D tissue cultures. |
Q33671117 | A novel technique to determine the cell type specific response within an in vitro co-culture model via multi-colour flow cytometry |
Q51621401 | A responsive human triple-culture model of the air-blood barrier: incorporation of different macrophage phenotypes. |
Q92977285 | ALI multilayered co-cultures mimic biochemical mechanisms of the cancer cell-fibroblast cross-talk involved in NSCLC MultiDrug Resistance |
Q34769423 | Activation of pulmonary dendritic cells and Th2-type inflammatory responses on instillation of engineered, environmental diesel emission source or ambient air pollutant particles in vivo |
Q89977338 | Air Pollution Emissions 2008-2018 from Australian Coal Mining: Implications for Public and Occupational Health |
Q45053539 | Air-Liquid Interface Cell Exposures to Nanoparticle Aerosols. |
Q46419437 | Airway epithelial cells enhance the immunogenicity of human myeloid dendritic cells under steady state. |
Q57048600 | Airway epithelial cells prime plasmacytoid dendritic cells to respond to pathogens via secretion of growth factors |
Q39702398 | Alternative Testing Strategies for Nanomaterials: State of the Science and Considerations for Risk Analysis |
Q99712168 | An Inflamed Human Alveolar Model for Testing the Efficiency of Anti-inflammatory Drugs in vitro |
Q28386849 | An improved 3D tetraculture system mimicking the cellular organisation at the alveolar barrier to study the potential toxic effects of particles on the lung |
Q28388825 | An in vitro alveolar macrophage assay for predicting the short-term inhalation toxicity of nanomaterials |
Q28395535 | An in vitro testing strategy towards mimicking the inhalation of high aspect ratio nanoparticles |
Q23919511 | An in vivo and in vitro toxicological characterisation of realistic nanoscale CeO2 inhalation exposures |
Q39138004 | Analytical in vitro approach for studying cyto- and genotoxic effects of particulate airborne material |
Q37955925 | Artificial airways for the study of respiratory disease. |
Q41681519 | Assessment of an in vitro model of pulmonary barrier to study the translocation of nanoparticles |
Q58493086 | Biological Effects in Lung Cells In Vitro of Exhaust Aerosols from a Gasoline Passenger Car With and Without Particle Filter |
Q55500005 | Biological response of an in vitro human 3D lung cell model exposed to brake wear debris varies based on brake pad formulation. |
Q28383482 | Biomechanical effects of environmental and engineered particles on human airway smooth muscle cells |
Q38901324 | Biomimetics of fetal alveolar flow phenomena using microfluidics. |
Q55258430 | Biomimetics of the pulmonary environment in vitro: A microfluidics perspective. |
Q39269818 | Cell cooperation and role of the P2X₇ receptor in pulmonary inflammation induced by nanoparticles. |
Q37994260 | Cell-based in vitro models for predicting drug permeability |
Q37400037 | Cellular uptake and cell-to-cell transfer of polyelectrolyte microcapsules within a triple co-culture system representing parts of the respiratory tract |
Q37869062 | Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials |
Q47225810 | Challenge in particle delivery to cells in a microfluidic device |
Q41497175 | Characteristics and properties of nano-LiCoO2 synthesized by pre-organized single source precursors: Li-ion diffusivity, electrochemistry and biological assessment |
Q50064805 | Chemotactic antiviral cytokines promote infectious apical entry of human adenovirus into polarized epithelial cells |
Q36220931 | Combined exposure of diesel exhaust particles and respirable Soufrière Hills volcanic ash causes a (pro-)inflammatory response in an in vitro multicellular epithelial tissue barrier model |
Q89340850 | Comparison of conventional and advanced in vitro models in the toxicity testing of nanoparticles |
Q42177249 | CpG DNA assists the whole inactivated H9N2 influenza virus in crossing the intestinal epithelial barriers via transepithelial uptake of dendritic cell dendrites |
Q28074825 | Critical review of the current and future challenges associated with advanced in vitro systems towards the study of nanoparticle (secondary) genotoxicity |
Q38928724 | Current in vitro approaches to assess nanoparticle interactions with lung cells |
Q58493237 | Dendritic Cells and Macrophages Form a Transepithelial Network against Foreign Particulate Antigens |
Q51492201 | Detection of respiratory allergies caused by environmental chemical allergen via measures of hyper-activation and degranulation of mast cells in lungs of NC/Nga mice. |
Q37570536 | Development of in vitro systems for nanotoxicology: methodological considerations |
Q37590222 | Diesel exhaust particle-treated human bronchial epithelial cells upregulate Jagged-1 and OX40 ligand in myeloid dendritic cells via thymic stromal lymphopoietin |
Q28391796 | Diesel exhaust particles modulate the tight junction protein occludin in lung cells in vitro |
Q26750759 | Diesel exhaust: current knowledge of adverse effects and underlying cellular mechanisms |
Q34463571 | Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages |
Q38920853 | Effect of Polarization on Airway Epithelial Conditioning of Monocyte-Derived Dendritic Cells |
Q34572681 | Effect of mouse strain in a model of chemical-induced respiratory allergy |
Q36649230 | Effects of flame made zinc oxide particles in human lung cells - a comparison of aerosol and suspension exposures |
Q39000791 | Efficient bioactive delivery of aerosolized drugs to human pulmonary epithelial cells cultured in air-liquid interface conditions |
Q38057778 | Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: potential solutions to current and future challenges |
Q30617839 | Engineering an in vitro air-blood barrier by 3D bioprinting |
Q37542225 | Engineering tissue alternatives to animals: applying tissue engineering to basic research and safety testing. |
Q35219780 | Epithelial Cells from Smokers Modify Dendritic Cell Responses in the Context of Influenza Infection |
Q35134068 | Epithelial cells, the "switchboard" of respiratory immune defense responses: effects of air pollutants |
Q39559529 | Epithelium damage and protection during reopening of occluded airways in a physiologic microfluidic pulmonary airway model |
Q39540435 | Evaluation of a physiological in vitro system to study the transport of nanoparticles through the buccal mucosa. |
Q28392779 | Experimental considerations on the cytotoxicity of nanoparticles |
Q28396160 | Expert consensus on an in vitro approach to assess pulmonary fibrogenic potential of aerosolized nanomaterials |
Q29248681 | Exposure of silver-nanoparticles and silver-ions to lung cells in vitro at the air-liquid interface |
Q34960453 | Fate of TLR-1/TLR-2 agonist functionalised pDNA nanoparticles upon deposition at the human bronchial epithelium in vitro |
Q36995437 | Human Airway Primary Epithelial Cells Show Distinct Architectures on Membrane Supports Under Different Culture Conditions |
Q40069891 | Human pulmonary 3D models for translational research |
Q102379327 | Immortalisation of primary human alveolar epithelial lung cells using a non-viral vector to study respiratory bioreactivity in vitro |
Q37098457 | Immortalization of human alveolar epithelial cells to investigate nanoparticle uptake. |
Q64242345 | In vitro detection of in vitro secondary mechanisms of genotoxicity induced by engineered nanomaterials |
Q58493113 | In vitro-ex vivo model systems for nanosafety assessment |
Q58493230 | In vitromodels of the human epithelial airway barrier to study the toxic potential of particulate matter |
Q36635066 | Inflammatory and oxidative stress responses of an alveolar epithelial cell line to airborne zinc oxide nanoparticles at the air-liquid interface: a comparison with conventional, submerged cell-culture conditions |
Q42066692 | Inhibitory kappaB kinase 2 activates airway epithelial cells to stimulate bone marrow macrophages. |
Q58493105 | Integrating silver compounds and nanoparticles into ceria nanocontainers for antimicrobial applications |
Q28382811 | Interaction and localization of synthetic nanoparticles in healthy and cystic fibrosis airway epithelial cells: effect of ozone exposure |
Q37080749 | Interactions of nanoparticles with pulmonary structures and cellular responses |
Q59048796 | Investigations of the Biological Effects of Airborne and Inhalable Substances by Cell-Based In Vitro Methods: Fundamental Improvements to the ALI Concept |
Q38126941 | Mechanisms of absorption and elimination of drugs administered by inhalation |
Q38819505 | Methodological considerations when conducting in vitro, air-liquid interface exposures to engineered nanoparticle aerosols. |
Q29248674 | Mimicking exposures to acute and lifetime concentrations of inhaled silver nanoparticles by two different in vitro approaches |
Q37906633 | Nanomaterial cell interactions: are current in vitro tests reliable? |
Q90177529 | Nanoparticle induced barrier function assessment at liquid-liquid and air-liquid interface in novel human lung epithelia cell lines |
Q37760469 | Nanotoxicology: a perspective and discussion of whether or not in vitro testing is a valid alternative |
Q37697804 | Non-animal sensitization testing: state-of-the-art |
Q36389587 | Optical tweezers reveal relationship between microstructure and nanoparticle penetration of pulmonary mucus |
Q39757824 | Oxidative stress and inflammation response after nanoparticle exposure: differences between human lung cell monocultures and an advanced three-dimensional model of the human epithelial airways |
Q35406276 | PVP-coated, negatively charged silver nanoparticles: A multi-center study of their physicochemical characteristics, cell culture and in vivo experiments |
Q26859438 | Physicochemical characteristics of nanomaterials that affect pulmonary inflammation |
Q38848644 | Pluripotent stem cells: An in vitro model for nanotoxicity assessments. |
Q37620365 | Preclinical models for pulmonary drug delivery |
Q21223673 | Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy |
Q36001471 | Progress and future of in vitro models to study translocation of nanoparticles. |
Q36253892 | Proinflammatory effects of cookstove emissions on human bronchial epithelial cells |
Q28390916 | Pulmonary surfactant coating of multi-walled carbon nanotubes (MWCNTs) influences their oxidative and pro-inflammatory potential in vitro |
Q34759412 | Quantification of gold nanoparticle cell uptake under controlled biological conditions and adequate resolution |
Q50267854 | Reactive indoor air chemistry and health-A workshop summary. |
Q51006717 | Repeated exposure to carbon nanotube-based aerosols does not affect the functional properties of a 3D human epithelial airway model. |
Q38166361 | Respiratory physiology on a chip |
Q47741693 | Respiratory sensitization: toxicological point of view on the available assays |
Q37754929 | Role of dendritic cells in the lung: in vitro models, animal models and human studies |
Q26852097 | State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology |
Q84303950 | Stem cells and cell therapies in lung biology and lung diseases |
Q36014064 | Stem cells and regenerative medicine in lung biology and diseases. |
Q46647478 | Synthesis and biocompatibility assessment of sugarcane bagasse-derived biogenic silica nanoparticles for biomedical applications |
Q58493078 | Synthesis, characterization, antibacterial activity and cytotoxicity of hollow TiO2-coated CeO2 nanocontainers encapsulating silver nanoparticles for controlled silver release |
Q84977772 | The Influence of Surface Composition of Nanoparticles on their Interactions with Serum Albumin |
Q38838210 | The effects of nanoparticles on the renal system |
Q64977942 | The impact of nanomaterial characteristics on inhalation toxicity. |
Q37729745 | Tissue-specific direct microtransfer of nanomaterials into Drosophila embryos as a versatile in vivo test bed for nanomaterial toxicity assessment |
Q33639595 | Toward a molecular understanding of nanoparticle-protein interactions |
Q30906151 | Toxic effects of brake wear particles on epithelial lung cells in vitro |
Q28383383 | Toxicological assessment of inhaled nanoparticles: role of in vivo, ex vivo, in vitro, and in silico studies |
Q23915033 | Tracking translocation of industrially relevant engineered nanomaterials (ENMs) across alveolar epithelial monolayers in vitro |
Q28397256 | Translocation of gold nanoparticles across the lung epithelial tissue barrier: Combining in vitro and in silico methods to substitute in vivo experiments |
Q28396932 | Translocation of particles and inflammatory responses after exposure to fine particles and nanoparticles in an epithelial airway model |
Q35134219 | Transmigration and phagocytosis of macrophages in an airway infection model using four-dimensional techniques |
Q57885152 | Triple-layered mixed co-culture model of RPE cells with neuroretina for evaluating the neuroprotective effects of adipose-MSCs |
Q36405765 | Ultrathin Ceramic Membranes as Scaffolds for Functional Cell Coculture Models on a Biomimetic Scale |
Q58493224 | Virosomes can enter cells by non-phagocytic mechanisms |
Search more.